This manufacturing facility is a commercial-scale cell and gene therapy facility operating as a contract development and manufacturing organization (CDMO). A CDMO works with other life sciences companies, large and small, to commercialize and manufacture their products. This arrangement allows life sciences companies to focus on research for new therapies and medical breakthroughs – and on growing their business. This new cell and gene therapy manufacturing facility secures the future of life sciences jobs and innovation in Ontario while advancing pioneering medicine with the potential to cure many forms of cancer, cardiovascular disease, Parkinson’s disease and diabetes.